OpenAlex
PricingAboutJobs
Log inGet started
Work

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

PubMed

Year: 2010
Type: article
Source: PubMed
Authors: Janina Geiler, Michael F McDermott
Institutions: St James's University Hospital, NIHR Leeds Musculoskeletal Biomedical Research Unit
Language: English

Topic: Inflammasome and immune disorders
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: gevokizumab, IL-1β, anti-IL-1β monoclonal antibody, type 1 diabetes, type 2 diabetes, rheumatoid arthritis, cardiovascular disease, uveitis, Behçet's disease, familial cold autoinflammatory syndrome, Muckle-Wells syndrome, autoinflammatory disease, vasculitis, humanized monoclonal antibody, innate immunity, anti-inflammatory therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W48003056
FWCI: 1.562
Cites:
Cited by: 48
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms